David E. Tabor
Impact in
- Biochemistry top 5%
- Lipid metabolism and biosynthesis
- Epidemiology top 5%
- Cervical Cancer and HPV Research
- Respiratory viral infections research
- Liver Disease Diagnosis and Treatment
Papers in
-
- Bacterial biofilms and quorum sensing 4
- Peroxisome Proliferator-Activated Receptors 3
- Epidemiology 10
- Respiratory viral infections research 5
- Co-authors
- Peter A. Edwards (3 shared papers)Bruce M. Spiegelman (2 shared papers)Jae Bum Kim (2 shared papers)Mark T. Esser (11 shared papers)Andrey Tovchigrechko (9 shared papers)Hong Jin (5 shared papers)Alexey Ruzin (7 shared papers)Bret R. Sellman (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Journal of Clinical Microbiology (2 papers)Journal of Biological Chemistry (2 papers)Clinical & Translational Immunology (2 papers)Biologicals (1 paper)
- Partner nations
- United StatesUnited KingdomFinland
In The Last Decade
David E. Tabor
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Biochemistry 150
- Epidemiology 507
- Infectious Diseases 224
- Clinical Biochemistry 82
- Microbiology 64
Countries citing papers authored by David E. Tabor
This map shows the geographic impact of David E. Tabor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Tabor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Tabor more than expected).
Fields of papers citing papers by David E. Tabor
This network shows the impact of papers produced by David E. Tabor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Tabor. The network helps show where David E. Tabor may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Tabor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 196 | |
| 2 | 1999 | 194 | |
| 3 | 1998 | 93 | |
| 4 | 2019 | 83 | |
| 5 | 2020 | 73 | |
| 6 | 2019 | 58 | |
| 7 | 2020 | 55 | |
| 8 | 2016 | 46 | |
| 9 | 2014 | 43 | |
| 10 | 2018 | 43 | |
| 11 | 2009 | 36 | |
| 12 | 1996 | 35 | |
| 13 | 1994 | 33 | |
| 14 | 2017 | 31 | |
| 15 | 1998 | 24 | |
| 16 | 2018 | 21 | |
| 17 | 2022 | 20 | |
| 18 | 2013 | 13 | |
| 19 | 1994 | 12 | |
| 20 | 2020 | 12 |
About David E. Tabor
David E. Tabor is a scholar working on Molecular Biology, Epidemiology, Infectious Diseases, Surgery and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (6 papers), Respiratory viral infections research (5 papers), Bacterial biofilms and quorum sensing (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Streptococcal Infections and Treatments (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Neonatal Respiratory Health Research (3 papers). The work is most often cited by research in Biochemistry (150 citations), Epidemiology (507 citations), Infectious Diseases (224 citations), Clinical Biochemistry (82 citations) and Microbiology (64 citations). David E. Tabor has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include Peter A. Edwards, Bruce M. Spiegelman, Jae Bum Kim, Mark T. Esser, Andrey Tovchigrechko, Hong Jin, Alexey Ruzin, Bret R. Sellman, Mark E. Sherman and Brenda B. Rush. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Biological Chemistry, Clinical & Translational Immunology and Biologicals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.